ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 339 filers reported holding ACCELERON PHARMA INC in Q3 2021. The put-call ratio across all filers is 0.38 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $2,458,000 | +52.9% | 14,285 | +11.5% | 0.01% | +40.0% |
| Q2 2021 | $1,608,000 | +26.6% | 12,815 | +36.8% | 0.01% | +25.0% |
| Q1 2021 | $1,270,000 | -3.1% | 9,368 | -8.5% | 0.00% | -20.0% |
| Q4 2020 | $1,310,000 | +10.3% | 10,240 | -3.0% | 0.01% | 0.0% |
| Q3 2020 | $1,188,000 | +44.9% | 10,553 | +22.7% | 0.01% | +25.0% |
| Q2 2020 | $820,000 | -8.2% | 8,602 | -13.4% | 0.00% | -33.3% |
| Q1 2020 | $893,000 | -4.2% | 9,936 | -43.5% | 0.01% | +50.0% |
| Q4 2019 | $932,000 | +21.4% | 17,583 | -9.5% | 0.00% | 0.0% |
| Q3 2019 | $768,000 | -6.5% | 19,431 | -2.8% | 0.00% | -20.0% |
| Q2 2019 | $821,000 | -20.9% | 19,994 | -10.3% | 0.01% | -16.7% |
| Q1 2019 | $1,038,000 | +20.8% | 22,291 | +13.0% | 0.01% | 0.0% |
| Q4 2018 | $859,000 | -36.1% | 19,734 | -16.0% | 0.01% | -33.3% |
| Q3 2018 | $1,345,000 | +13.9% | 23,495 | -3.4% | 0.01% | +12.5% |
| Q2 2018 | $1,181,000 | +17.0% | 24,333 | -5.7% | 0.01% | +14.3% |
| Q1 2018 | $1,009,000 | -20.6% | 25,799 | -13.8% | 0.01% | -22.2% |
| Q4 2017 | $1,271,000 | +42.0% | 29,941 | +24.8% | 0.01% | +12.5% |
| Q3 2017 | $895,000 | +30.1% | 23,989 | +5.9% | 0.01% | +14.3% |
| Q2 2017 | $688,000 | +11.5% | 22,655 | -2.8% | 0.01% | +16.7% |
| Q1 2017 | $617,000 | -17.6% | 23,301 | -20.6% | 0.01% | -25.0% |
| Q4 2016 | $749,000 | -23.1% | 29,339 | +9.0% | 0.01% | -42.9% |
| Q3 2016 | $974,000 | -7.7% | 26,911 | -13.3% | 0.01% | 0.0% |
| Q2 2016 | $1,055,000 | +31.2% | 31,057 | +2.0% | 0.01% | +27.3% |
| Q1 2016 | $804,000 | -44.9% | 30,453 | +1.8% | 0.01% | -38.9% |
| Q4 2015 | $1,458,000 | +114.7% | 29,906 | +9.6% | 0.02% | +80.0% |
| Q3 2015 | $679,000 | -25.9% | 27,287 | -5.8% | 0.01% | -23.1% |
| Q2 2015 | $916,000 | -17.5% | 28,957 | -0.7% | 0.01% | 0.0% |
| Q1 2015 | $1,110,000 | +14.4% | 29,162 | +17.1% | 0.01% | +18.2% |
| Q4 2014 | $970,000 | +256.6% | 24,893 | +210.5% | 0.01% | +175.0% |
| Q2 2014 | $272,000 | +9.7% | 8,017 | +11.5% | 0.00% | +33.3% |
| Q1 2014 | $248,000 | – | 7,190 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 42,030 | $3,777,000 | 6.01% |
| Artal Group S.A. | 1,500,000 | $134,805,000 | 5.70% |
| GREAT POINT PARTNERS LLC | 535,627 | $48,137,000 | 5.03% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 211,038 | $18,966,000 | 3.47% |
| Cormorant Asset Management, LP | 825,000 | $74,143,000 | 3.44% |
| Graticule Asia Macro Advisors LLC | 48,700 | $4,377,000 | 3.20% |
| Avoro Capital Advisors LLC | 860,000 | $77,288,000 | 2.61% |
| QVT Financial LP | 120,264 | $10,808,000 | 2.52% |
| Ikarian Capital, LLC | 316,900 | $28,480,000 | 2.14% |
| Avidity Partners Management LP | 166,000 | $14,918,000 | 2.06% |